Course Organiser: F. Behar-Cohen SWITZERLAND
A. Urtti FINLAND
Posterior segment pharmokinetics
R. Herrero-Vanrell SPAIN
Microparticles as therapeutic tools in retinal diseases
E. Stefánsson ICELAND
Cyclodextrin nanoparticle eye drops for retinal diseases
F. Behar-Cohen SWITZERLAND
Viral / non-viral gene delivery for retinal diseases
– Is intravitreous route optimal to target chorio-retinal diseases?
– Can we reduce drug doses and maintain long-term effects?
– What are the obstacles for clinical use of particulate systems?
– The place of gene therapy in clinical practice
End of sessionBack